- Global Pharma News & Resources

Ankylosing Spondylitis Treatment Market players focusing on innovation & regulatory approvals

Concerning ankylosing spondylitis, the healthcare industry is moving towards comprehensive research to proceed with the geometric progression in the number of inventions., which is driving the market. Ankylosing spondylitis is a chronic inflammatory disease that affects the spine. It is a type of arthritis, in which spine bones grow or fuse together, causing the spine to become rigid. Symptoms of ankylosing spondylitis include pain and stiffness from the neck to the lower back, bony fusion, and pain in the ligaments and tendons. These symptomatic changes may be mild or severe, and may lead to a stooped-over posture

FMI states in its recent study on the ankylosing spondylitis treatment market that the market will record a steady CAGR through 2030. Demand for Ankylosing spondylitis is anticipated to continue surging because the governments are diverting a greater portion of their revenue towards extensive research

“An increasing demand for nonsteroidal anti-inflammatory drugs through oral route of administration coupled with new product launches in this regard is likely to fuel the ankylosing spondylitis treatment market.” says the FMI analyst.

Request a report sample to gain comprehensive market insights at

Ankylosing spondylitis Market – Important Highlights

  • “Adults” contribute to most revenue generation by age group, as ankylosing spondylitis is typically started in adulthood.
  • The market is dominated by non-steroidal anti-inflammatory drugs as they are used as the first line of treatment for ankylosing spondylitis.
  • Due to the ease of consumption, oral administration routes have the largest market share.
  • The Hospitals Pharmacy segment is projected to have the largest market share concerning the distribution channel.
  • Due to the well-established healthcare system, high incidences of ankylosing spondylitis, and developments in the pharmaceutical industry, North America, led by the US, has the largest market share.

Ankylosing spondylitis Market – Drivers

  • Market Players are Focusing on R&D and Innovations which is driving the growth of the market.
  • Favorable government policies and investments in the healthcare sector are anticipated to contribute to the growth of the market.
  • Increasing demand for non-steroidal anti-inflammatory drugs through oral administration routes coupled with new product launches in this regard is likely to fuel the market for ankylosing spondylitis therapy

North America dominates the global market for ankylosing spondylitis treatment due to the high prevalence of the disease and increased adoption of ankylosing spondylitis treatment options in the region. In addition, technological advancements are driving ankylosing spondylitis treatment in North America. Asia, followed by Europe, is expected to experience high growth rate in the ankylosing spondylitis treatment market over the next few years. China and India are expected to be the fastest-growing ankylosing spondylitis treatment markets in the Asian region. Some of the key driving forces for ankylosing spondylitis treatment market in emerging countries are a large pool of patients and rising government initiatives in the form of funding.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization@

Ankylosing spondylitis Market – Restraints

  • The lack of qualified surgeons and physiotherapists is hampering the growth of the market.
  • High medical costs are anticipated to remain a market restraint during the forecast era.

COVID-19 Impact on ankylosing spondylitisMarket

After the outbreak of Covid-19, demand for ankylosing spondylitis has experienced a decline in demand. The pandemic has led to a decrease in the patient’s flow in the hospitals, and doctor chambers. As the attention of health care services changes to emergency COVID-19 care, treatment is de-prioritized for other illnesses and injuries. However, this is estimated to be a temporary effect and the market is expected to have a turnaround with the stabilization of the economy.

Competitive Landscape

· The Ankylosing spondylitis market players are leaning towards the expansion of the production facilities besides opting for strategic collaborations to attain a competitive edge. Concerning ankylosing spondylitis, the healthcare industry is moving towards comprehensive research to proceed with the geometric progression in the number of inventions. For instance, In June 2020, Celltrion Healthcare received CHMP (Committee for Medical Drugs for Human Use) recommendations for the use of Remsima in ankylosing spondylitis.

Some of the prominent players listed in the global Ankylosing spondylitis market are Wyeth, Mitsubishi Tanabe, Schering-Plough, Takeda, Amgen, Centocor

Contact Sales for Further Assistance in Purchasing this Report@

Table Of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Product Adoption / Usage Analysis

4.2. Product USPs / Features

4.3. Key Promotional Strategies

5. Global Ankylosing spondylitis Treatment Market – Pricing Analysis

5.1. Regional Pricing Analysis By Drug Class

5.2. Pricing Break-up

5.2.1. Manufacturer Level Pricing

5.2.2. Distributor Level Pricing

5.3. Global Average Pricing Analysis Benchmark

6. Global Ankylosing spondylitis Treatment Market Demand (in Value or Value in US$ Mn) Analysis 2015-2019and Forecast, 2020-2030

6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

6.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

6.2.1. Y-o-Y Growth Trend Analysis

6.2.2. Absolute $ Opportunity Analysis

Download Complete TOC Of this Report @

About the Study

The study offers readers a comprehensive assessment of the Ankylosing spondylitis market. Global, regional, and national-level analysis of the latest trends influencing the market is covered in this FMI report. The study provides insights based on drug class (Nonsteroidal Anti-inflammatory Drugs, Anti-Inflammatory Drugs, Immunosuppressive Drugs, TNF Blockers, JAK Inhibitors, Steroids, Biologics, Others), application(adults, juveniles) and across key regions (North America, Latin America, Europe, China, Asia Pacific, Middle East & Africa).

Explore FMI’s Coverage of the healthcareIndustry

Respiratory devices market: Get insights on the respiratory devices market through FMI’s report covering detailed quantitative and qualitative analysis for the projection period 2021-20301

localized temperature therapy products market: FMI’s exhaustive study on the localized temperature therapy products market covers the latest trends, innovations, key players, and popular strategies for the period 2020-2030.

Infusion pumps market: Obtain detailed analysis on the infusion pumps market through FMI’s report covering competitive analysis, key regions, and segmental analysis for 2020-2030.

About Future Market Insights

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.


Mr. Abhishek Budholiya

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates


For Sales Enquiries:

For Media Enquiries:


Press Release Source:

Editor Details

Last Updated: 03-Mar-2021